FAIRFIELD, Iowa, April 20, 2017 — Hedge funds gained 0.53% in March according to the Barclay Hedge Fund Index compiled by BarclayHedge, extending its string of wins to a fifth consecutive month. For the first quarter of 2017, the Index was up 2.99%.
“The ongoing global equity rally has been a significant driver of returns for the past five months,” says Sol Waksman, founder and president of BarclayHedge.
Fifteen of Barclay’s 17 hedge fund indices gained ground in March. The Technology Index was up 2.26%, Healthcare and Biotechnology gained 1.41%, European Equities were up 1.22%, Emerging Markets gained 1.15%, and the Pacific Rim Equities Index added 0.81%.
The only losing hedge fund strategies in March were the Distressed Securities Index, which was down 1.44%, and the Global Macro Index which slipped 0.02%.
At the end of the first quarter, all of Barclay’s hedge fund indices are in positive territory. The Healthcare and Biotechnology Index is up 7.54%, Technology has gained 6.84%, Emerging Markets are up 5.81%, Equity Long Bias has gained 3.47%, and the European Equities Index is up 3.17%.
The Barclay Fund of Funds Index gained 0.48% in March, and is up 2.07% in 2017.
Click here to view five years of Barclay Hedge Fund Index data, or to download 20 years of monthly data.
Sol Waksman is an experienced media source, providing perspectives on hedge fund and managed futures trends. For more commentary or background, call 641-472-3456 or email swaksman@barclayhedge.com.
BarclayHedge is the global leader in providing independent, research-based information services to the alternative investment industry. Founded in 1985, Barclay currently maintains data on more than 6,400 hedge funds, fund of funds, and CTAs. No one has been in the business of collecting alternative investment data longer than BarclayHedge.
Institutional investors, brokerage firms, and private banks worldwide utilize BarclayHedge indices as performance benchmarks for the hedge fund and managed futures industries.